John Maraganore, Chief Executive Officer at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 98,912 shares at $80.31 ($7.9M) on 2019-10-14, disclosed to the SEC on 2019-10-16.
Open-market sale of $7.9M ALNY by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $78.92 | 20,832 | $1.6M | 20.9% |
| 2 | $78.92 | 20,832 | $1.6M | 20.9% |
| 3 | $79.80 | 26,754 | $2.1M | 27.2% |
| 4 | $79.80 | 26,754 | $2.1M | 27.2% |
| 5 | $80.31 | 1,870 | $150K | 1.9% |
| 6 | $80.31 | 1,870 |
| $150K |
| 1.9% |
| Total | $79.45 avg | 98,912 | $7.9M | 100% |
| Filing → |
| ALNY | SELL | 2021-05-17 | $8.9M | — | Filing → |
| ALNY | SELL | 2021-02-26 | $9.4M | — | Filing → |
| ALNY | SELL | 2020-11-20 | $8.6M | — | Filing → |